ArticleDrugs - real world outcomes2020

Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™).

Joseph Reilly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.